DANIEL BAYLISS LTD

Company number 13208435 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

DANIEL BAYLISS LTD - Analysis Report

Company Number: 13208435

Analysis Date: 2025-07-29 12:19 UTC

Financial Health Assessment: DANIEL BAYLISS LTD (as of 31 March 2025)


1. Financial Health Score: B+

Explanation: DANIEL BAYLISS LTD displays sound financial stability with strong liquidity and improving net assets. While the company is small (micro-entity) and relatively young, it shows healthy working capital and a positive equity base, indicating a solid financial foundation. Some caution is advised due to limited scale and reliance on director loans, but overall the financial "vitals" are robust.


2. Key Vital Signs

Metric Value (2025) Interpretation
Fixed Assets £2,840 Low fixed assets typical for a consultancy; suggests light capital investment, good flexibility.
Current Assets £35,100 Healthy pool of liquid assets (cash, receivables), indicating good short-term resource availability.
Current Liabilities £8,399 Manageable short-term debt; current assets exceed liabilities by over 3 times (Net Current Assets).
Net Current Assets (Working Capital) £26,701 Strong working capital, a "healthy cash flow" symptom ensuring smooth operations without liquidity stress.
Net Assets/Shareholders Funds £29,541 Positive and growing equity base, reflecting retained earnings and financial strength.
Share Capital £100 Minimal share capital typical for a small private company; does not affect financial health directly.
Director Loan £21,617 (owed to director) Indicates reliance on internal financing; unsecured and interest-free, but may carry risk if not repaid timely.

Additional Observations:

  • Employee Count: No employees other than possibly the director, reflecting low overheads but limited operational scale.
  • Exemption from Audit: The company qualifies for audit exemption under micro-entity rules, indicating simplicity but also less external scrutiny.
  • Industry: Management consultancy (SIC 70229), low asset intensity and service-based.

3. Diagnosis: Financial Condition

DANIEL BAYLISS LTD exhibits symptoms of good financial health, especially for a micro-entity in its early years. The company shows a consistent upward trajectory in net assets—from £2,153 in 2021 to £29,541 in 2025—demonstrating retained profitability and prudent capital management.

Liquidity is strong with current assets comfortably covering short-term liabilities; this is akin to a patient with a stable pulse and clear breathing—no immediate liquidity distress. The growing net current assets illustrate a healthy cash flow and the ability to meet operational expenses and short-term debts without strain.

The presence of a director loan of £21,617 as a current asset (amount owed to the company by the director) is somewhat unusual and suggests internal transactions for working capital purposes. While this is interest-free and repayable on demand, it may indicate reliance on internal funding rather than external credit, which could be a vulnerability if the director’s financial position changes.

The company's minimal fixed assets align with its consultancy nature, requiring few physical resources. The absence of employees other than the director keeps costs low but may limit growth potential.

Overall, this company resembles a young, fit patient with a strong constitution but requiring monitoring to ensure sustainable growth and to avoid over-reliance on director loans.


4. Recommendations: Steps to Improve Financial Wellness

  • Strengthen Capital Base: Consider increasing share capital or seeking external equity investment to reduce reliance on director loans and improve financial resilience.
  • Formalize Director Loan Terms: Document clear repayment plans or convert director loans into formal long-term financing with appropriate terms to mitigate risk.
  • Build Cash Reserves: Maintain or increase cash reserves to safeguard against unforeseen expenses or economic downturns.
  • Plan for Growth: Explore opportunities for hiring or expanding services to diversify revenue streams and reduce single-person operational risk.
  • Regular Financial Reviews: Conduct periodic financial health checks to monitor liquidity, profitability, and capital structure as the business scales.
  • Compliance and Governance: Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.